11-45909951-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004813.4(PEX16):​c.*303C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.628 in 788,526 control chromosomes in the GnomAD database, including 170,113 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 26496 hom., cov: 34)
Exomes 𝑓: 0.65 ( 143617 hom. )

Consequence

PEX16
NM_004813.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.311

Publications

8 publications found
Variant links:
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 8A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • peroxisome biogenesis disorder 8B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 11-45909951-G-A is Benign according to our data. Variant chr11-45909951-G-A is described in ClinVar as [Benign]. Clinvar id is 304781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.725 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX16NM_004813.4 linkc.*303C>T 3_prime_UTR_variant Exon 11 of 11 ENST00000378750.10 NP_004804.2 Q9Y5Y5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX16ENST00000378750.10 linkc.*303C>T 3_prime_UTR_variant Exon 11 of 11 1 NM_004813.4 ENSP00000368024.5 Q9Y5Y5-1
PEX16ENST00000241041.7 linkc.*138C>T 3_prime_UTR_variant Exon 11 of 11 1 ENSP00000241041.3 Q9Y5Y5-2
PEX16ENST00000523721.2 linkn.*219C>T downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.535
AC:
81330
AN:
152092
Hom.:
26501
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.174
Gnomad AMI
AF:
0.780
Gnomad AMR
AF:
0.561
Gnomad ASJ
AF:
0.775
Gnomad EAS
AF:
0.194
Gnomad SAS
AF:
0.571
Gnomad FIN
AF:
0.689
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.730
Gnomad OTH
AF:
0.595
GnomAD4 exome
AF:
0.651
AC:
414088
AN:
636316
Hom.:
143617
Cov.:
8
AF XY:
0.653
AC XY:
220714
AN XY:
337832
show subpopulations
African (AFR)
AF:
0.176
AC:
3107
AN:
17674
American (AMR)
AF:
0.489
AC:
17644
AN:
36086
Ashkenazi Jewish (ASJ)
AF:
0.768
AC:
14508
AN:
18894
East Asian (EAS)
AF:
0.155
AC:
5244
AN:
33904
South Asian (SAS)
AF:
0.585
AC:
36793
AN:
62844
European-Finnish (FIN)
AF:
0.696
AC:
24111
AN:
34660
Middle Eastern (MID)
AF:
0.708
AC:
1763
AN:
2490
European-Non Finnish (NFE)
AF:
0.731
AC:
289733
AN:
396618
Other (OTH)
AF:
0.639
AC:
21185
AN:
33146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
6907
13814
20722
27629
34536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2808
5616
8424
11232
14040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.534
AC:
81321
AN:
152210
Hom.:
26496
Cov.:
34
AF XY:
0.532
AC XY:
39610
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.173
AC:
7199
AN:
41532
American (AMR)
AF:
0.560
AC:
8571
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.775
AC:
2688
AN:
3470
East Asian (EAS)
AF:
0.193
AC:
1002
AN:
5180
South Asian (SAS)
AF:
0.571
AC:
2756
AN:
4826
European-Finnish (FIN)
AF:
0.689
AC:
7303
AN:
10606
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.730
AC:
49627
AN:
67974
Other (OTH)
AF:
0.598
AC:
1262
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1519
3039
4558
6078
7597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
670
1340
2010
2680
3350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.659
Hom.:
61169
Bravo
AF:
0.507
Asia WGS
AF:
0.398
AC:
1390
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Peroxisome biogenesis disorder 8A (Zellweger) Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.33
DANN
Benign
0.59
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10838529; hg19: chr11-45931502; COSMIC: COSV53796581; COSMIC: COSV53796581; API